[1] 中华医学会呼吸病学分会.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核呼吸杂志,2008,31(3):177-185. [2] Global initiative for asthma. Global strategy for asthma management and prevention. global initiative for asthma (updated 2012)[EB/OL]. Available from http://www.ginasthma.org. [3] Turato G,Barbato A,Baraldo S,et al.Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma[J].Am J Respir Crit Care Med,2008,178(5):476-482. [4] Nicolini G,Cremonesi G,Melani AS,et al. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate [J].Pulm Pharmacol Ther,2010, 23(3):145-155. [5] Baker JW,Mellon M,Wald J,et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants[J].Pediatrics ,1999,103(2):414-421. [6] 贾黎红,严娟娟.雾化吸入布地奈德与口服孟鲁司特治疗咳嗽变异性哮喘比较研究[J].中国临床药理学与治疗学,2012,17(7):816-820. [7] 李臻,陈育智,陈爱欢,等.压缩式吸入器雾化吸入布地奈德治疗5岁以下儿童哮喘临床观察[J].临床儿科杂志,2008,26(3):226-229. [8] 顾晓虹,谢娟娟.布地奈德雾化吸入治疗婴幼儿喘息的疗效观察[J].临床肺科杂志,2013,18(8):1387-1389. [9] 刘永强,尹娟. 布地奈德混悬液对支气管哮喘慢性持续期患者骨密度的影响[J]. 临床和实验医学杂志, 2013,12(2):101-102. [10] Ediger D,Coskun F,Kunt Uzaslan E,et al.Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks[J].Tuberk Toraks,2006,54(2):128-136. [11] Murphy K,Noonan M,Silkoff PE,et al. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler [J].Cli Ther,2007,29(6):1013-1026. [12] Cottini M,Asero R. Asthma phenotypes today[J].Eur Ann Allergy Clin Immunol,2013,45(1):17-24. |